CARCINOMA, PANCREATIC DUCTAL
Clinical trials for CARCINOMA, PANCREATIC DUCTAL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, PANCREATIC DUCTAL trials appear
Sign up with your email to follow new studies for CARCINOMA, PANCREATIC DUCTAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for pancreatic cancer: drug combo trial launches
Disease control Recruiting nowThis study tests a new drug called relacorilant combined with two standard chemotherapy drugs for people with advanced pancreatic cancer that has spread. The goal is to see if the combination can help control the cancer longer and improve survival. About 60 participants will rece…
Matched conditions: CARCINOMA, PANCREATIC DUCTAL
Phase: PHASE2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New pill targets KRAS mutations in Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new experimental drug, PF-07934040, for people with advanced solid tumors that have a KRAS gene mutation. The drug is taken as a pill twice a day, either alone or with other anti-cancer medicines given by IV. The goal is to find the safest dose and see if the d…
Matched conditions: CARCINOMA, PANCREATIC DUCTAL
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
Gene test could guide chemo choice for tough pancreatic cancer
Knowledge-focused Recruiting nowThis study aims to see if using genetic signatures from a liver biopsy can help doctors choose the most effective first chemotherapy for people with advanced pancreatic cancer. About 85 participants will have their treatment selected based on these genetic tests, and researchers …
Matched conditions: CARCINOMA, PANCREATIC DUCTAL
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC